Volatile anesthetics inhibit calcitonin gene-related peptide receptor-mediated responses in pithed rats and human neuroblastoma cells

Journal of Pharmacology and Experimental Therapeutics

Volumn 311, Issue 3, 2004, Pages 1016-1022

  Kuroda, Masataka ^a   Yoshikawa, Daisuke ^a   Nishikawa, Koichi ^a   Saito, Shigeru ^a   Goto, Fumio ^a  

^a GUNMA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADENYLATE CYCLASE; CALCITONIN GENE RELATED PEPTIDE RECEPTOR; CHOLERA TOXIN; FORSKOLIN; INHALATION ANESTHETIC AGENT; ISOFLURANE; SEVOFLURANE; STIMULATORY GUANINE NUCLEOTIDE BINDING PROTEIN;

ALTERNATIVE RNA SPLICING; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BINDING AFFINITY; CONTINUOUS INFUSION; CONTROLLED STUDY; DRUG EFFECT; DRUG INHIBITION; ENZYME ACTIVATION; HEART OUTPUT; LIGAND BINDING; MEAN ARTERIAL PRESSURE; NEUROBLASTOMA CELL; NONADRENERGIC NONCHOLINERGIC NERVE; NONHUMAN; NORADRENALIN RELEASE; PRIORITY JOURNAL; RAT; RECEPTOR BINDING; SIGNAL TRANSDUCTION; SMOOTH MUSCLE RELAXATION; SPINAL ANIMAL; VASCULAR RESISTANCE;

ANESTHETICS, INHALATION; ANIMALS; BRAIN NEOPLASMS; CALCITONIN GENE-RELATED PEPTIDE; CELL LINE, TUMOR; CHOLERA TOXIN; CYCLIC AMP; DECEREBRATE STATE; DOSE-RESPONSE RELATIONSHIP, DRUG; FORSKOLIN; HEMODYNAMIC PROCESSES; HUMANS; MALE; NEUROBLASTOMA; RADIOLIGAND ASSAY; RATS; RATS, WISTAR; RECEPTORS, CALCITONIN GENE-RELATED PEPTIDE; SIGNAL TRANSDUCTION;

EID: 10044232750     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: 10.1124/jpet.104.071936     Document Type: Article

References (32)

1. Anthony BL, Dennison RL, and Aronstam RS (1989) Disruption of muscarinic receptor-G protein coupling is a general property of liquid volatile anesthetics. Neurosci Lett 99:191-196.
2. Bell D and McDermott BJ (1996) Calcitonin gene-related peptide in the cardiovascular system: characterization of receptor populations and their (patho)physiological significance. Pharmacol Rev 48:253-288.
3. Bevan JA and Brayden JE (1987) Nonadrenergic neural vasodilator mechanisms. Circ Res 60:309-326.
4. Bradford MM (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248-254.
5. Choksi T, Hay DL, Legon S, Poyner DR, Hagner S, Bloom SR, and Smith DM (2002) Comparison of the expression of calcitonin receptor-like receptor (CRLR) and receptor activity modifying proteins (RAMPs) with CGRP and adrenomedullin binding in cell lines. Br J Pharmacol 136:784-792.
6. Franks NP and Lieb WR (1994) Molecular and cellular mechanisms of general anaesthesia. Nature (Lond) 367:607-614.
7. Gillespie JS and Muir TC (1967) A method of stimulating the complete sympathetic outflow from the spinal cord to blood vessels in the pithed rat. Br J Pharmacol 30:78-87.
8. Gray GA, Furman BL, and Parratt JR (1990) Endotoxin-induced impairment of vascular reactivity in the pithed rat: role of arachidonic acid metabolites. Circ Shock 31:395-406.
9. Henriksen JH, Schifter S, Moller S, and Bendtsen F (2000) Increased circulating calcitonin in cirrhosis. Relation to severity of disease and calcitonin gene-related peptide. Metabolism 49:47-52.
10. Jacob JE, Pniak A, Weaver LC, and Brown A (2001) Autonomic dysreflexia in a mouse model of spinal cord injury. Neuroscience 108:687-693.
11. Kawasaki H, Takasaki K, Saito A, and Goto K (1988) Calcitonin gene-related peptide acts as a novel vasodilator neurotransmitter in mesenteric resistance vessels of the rat. Nature (Lond) 335:164-167.
12. Lambert DG (1993) Signal transduction: G proteins and second messengers. Br J Anaesth 71:86-95.
13. McLatchie LM, Fraser NJ, Main MJ, Wise A, Brown J, Thompson N, Solari R, Lee MG, and Foord SM (1998) RAMPs regulate the transport and ligand specificity of the calcitonin-receptor-like receptor. Nature (Lond) 393:333-339.
14. Moreno MJ, Abounader R, Hebert E, Doods H, and Hamel E (2002) Efficacy of the non-peptide CGRP receptor antagonist BIBN4096BS in blocking CGRP-induced dilations in human and bovine cerebral arteries: potential implications in acute migraine treatment. Neuropharmacology 42:568-576.
15. Muff R, Stangl D, Born W, and Fischer JA (1992) Comparison of a calcitonin gene-related peptide receptor in a human neuroblastoma cell line (SK-N-MC) and a calcitonin receptor in a human breast carcinoma cell line (T47D). Ann N Y Acad Sci 657:106-116.
16. Neer EJ and Clapham DE (1988) Roles of G protein subunits in transmembrane signalling. Nature (Lond) 333:129-134.
17. Orlandi PA, Curran PK, and Fishman PH (1993) Brefeldin A blocks the response of cultured cells to cholera toxin. Implications for intracellular trafficking in toxin action. J Biol Chem 268:12010-12016.
18. Pentyala SN, Sung K, Chowdhury A, and Rebecchi MJ (1999) Volatile anesthetics modulate the binding of guanine nucleotides to the alpha subunits of heterotrimeric GTP binding proteins. Eur J Pharmacol 384:213-222.
19. Poyner DR, Soomets U, Howitt SG, and Langel U (1998) Structural determinants for binding to CGRP receptors expressed by human SK-N-MC and Col 29 cells: studies with chimeric and other peptides. Br J Pharmacol 124:1659-1666.
20. Sanuki M, Yuge O, Kawamoto M, Fujii K, and Azuma T (1994) Sevoflurane inhibited beta-adrenoceptor-G protein bindings in myocardial membrane in rats. Anesth Analg 79:466-471.
21. Saxena PR and Villalon CM (1990) Cardiovascular effects of serotonin agonists and antagonists. J Cardiovasc Pharmacol 15:17-34.
22. Scatchard G (1949) The attraction of proteins for small molecules and ions. Ann N Y Acad Sci 51:660-672.
23. Shiga T and Yoshikawa D (1995) Platelet-activating factor-induced loss of vascular responsiveness to noradrenaline in pithed rats: involvement of nitric oxide. Eur J Pharmacol 282:151-156.
24. 2+ mobilization in cultured vascular smooth muscle cells. J Pharmacol Exp Ther 265:74-80.
25. Streiff J, Jones K, Perkins WJ, Warner DO, and Jones KA (2003) Effect of halothane on the guanosine 5′ triphosphate binding activity of G-protein alpha i subunits. Anesthesiology 99:105-111.
26. Taguchi T, Kawasaki H, Imamura T, and Takasaki K (1992) Endogenous calcitonin gene-related peptide mediates nonadrenergic noncholinergic depressor response to spinal cord stimulation in the pithed rat. Circ Res 71:357-364.
27. Tanaka S and Tsuchida H (1998) Effects of halothane and isoflurane on beta-adrenoceptor-mediated responses in the vascular smooth muscle of rat aorta. Anesthesiology 89:1209-1217.
28. Terazawa E, Dohi S, Akamastsu S, Ohata H, and Shimonaka H (2003) Changes in calcitonin gene-related peptide, atrial natriuretic peptide and brain natriuretic peptide in patients undergoing coronary artery bypass grafting. Anaesthesia 58:223-232.
29. van Rossum D, Hanisch UK, and Quirion R (1997) Neuroanatomical localization, pharmacological characterization and functions of CGRP, related peptides and their receptors. Neurosci Biobehav Rev 21:649-678.
30. Van Valen F, Piechot G, and Jurgens H (1990) Calcitonin gene-related peptide (CGRP) receptors are linked to cyclic adenosine monophosphate production in SK-N-MC human neuroblastoma cells. Neurosci Lett 119:195-198.
31. Yoshikawa D, Kuroda M, Tsukagoshi H, Takahashi K, Saito S, Nishikawa K, and Goto F (2003) The effects of volatile anesthetics on nonadrenergic, noncholinergic depressor responses in rats. Anesth Analg 96:125-131.
32. Yoshikawa D, Shiga T, Saito S, Morita T, Imai T, and Goto F (1998) Platelet-activating factor receptor antagonist attenuates endotoxin-induced vascular hyporeactivity in the pithed rat. Eur J Pharmacol 342:241-245.